Adherence to proven protocols for disinfecting surgeons’ hands, patients’ skin, and operating room surfaces could help to halt the spread of dangerous Staphylococcus aureus (S.
Fomite-mediated transmission can be an important pathway causing significant disease transmission in number of settings such as schools, daycare centers and long-term care facilities.
A one-fifth dose of yellow fever vaccine protects against yellow fever for 10 years and does not require a booster.
USC researchers have developed a polio vaccine that doesn't require refrigeration, meaning it could someday be used all over the world to deliver the final blow to this longtime foe.
Hand hygiene (HH) compliance has been shown to be poor in studies. Improving the availability of alcohol-based hand rub (ABHR) is a cornerstone for increasing HH compliance.
A new candidate HIV vaccine from Scripps Research surmounts technical hurdles that stymied previous vaccine efforts, and stimulates a powerful anti-HIV antibody response in animal tests.
ECRI Institute, an independent, nonprofit patient safety organization, has launched the ECRI Guidelines Trust™, a portal to expertly vetted, evidence-based guideline briefs and scorecards.
About half of all people with cystic fibrosis, the most common genetic disorder in the United States, die from a lung disease before they turn 40. A form of pneumonia called Pseudomonas aeruginosa is a likely culprit.
A team of scientists at Boston Children's Hospital has developed the first modeling system for testing age-specific human immune responses to vaccines -- outside the body.
The Food and Drug Administration (FDA) announces it has approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool.